NR1I3 and obesity disorder: Recent studies revealed that activation of constitutive androstane receptor (CAR) which is highly expressed in the liver, prevents diet-induced obesity, reduces hepatic steatosis, improves insulin sensitivity [83], and ameliorates diabetes and fatty liver disease in mice [84].